DEPDC1B and melanoma: An increasing body of evidence clarified that abnormal overexpression of DEPDC1B in diverse types of cancers, including non-small cell lung cancer, soft tissue sarcoma, cervical cancer, malignant melanoma, and hepatocellular cancer23–27.